Ambalal Sarabhai Enterprises P/B Ratio
Ambalal Sarabhai Enterprises (AMBALALSA) P/B ratio is 1.68 (Moderate), book value per share ₹18.18 vs Healthcare average P/B of -0.94 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see AMBALALSA stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
AMBALALSA P/B Ratio — Valuation Insights & Book Value Analysis
Ambalal Sarabhai Enterprises price-to-book ratio interpretation, valuation status and historical context — current P/B 1.68 (Moderate). View AMBALALSA annual price range for the annual high/low range and current price position.
- Current PB is 30.3% below historical average
- Trading at premium to sector average PB of -0.94
Ambalal Sarabhai Enterprises P/B Ratio Historical Trend
AMBALALSA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with AMBALALSA fair value to assess whether the stock is under or overvalued.
AMBALALSA Historical P/B Ratio — Book Value Per Share & Year-End Price
Ambalal Sarabhai Enterprises annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.57 | ₹18.18 | ₹28.58 | ₹140 | Moderate |
| 2024 | 3.03 | ₹17.66 | ₹53.58 | ₹136 | High |
| 2023 | 2.23 | ₹17.01 | ₹38.02 | ₹131 | Moderate |
| 2022 | 1.73 | ₹15.58 | ₹26.90 | ₹120 | Moderate |
| 2021 | 3.5 | ₹9.61 | ₹33.65 | ₹74 | High |
AMBALALSA vs Healthcare Peers — P/B Ratio Comparison
Ambalal Sarabhai Enterprises P/B 1.68 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |